Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GILEAD SCIENCES, INC. Director's Dealing 2016

Aug 2, 2016

29828_dirs_2016-08-02_8e0392f4-1506-4cff-9eb8-2b0c8b4b3d44.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2016-07-31

Reporting Person: Carter Paul Rutherford (EVP Commercial Ops)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-07-31 Common Stock M 2500 Acquired 63622 Direct
2016-07-31 Common Stock F 1317 $79.47 Disposed 62305 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-07-31 Restricted Stock Unit $ M 2500 Disposed Common Stock (2500) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2: The restricted stock units vest 25% annually over a four year period after the date of grant.